MIT
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
MIT
May 13, 2024, 07:43 |
Insight
Johnathan Ebben: There are more free floating mitochondria in circulation than WBCs?
Johnathan Ebben, Oncology Fellow at the University of Wisconsin-Madison, shared a post by Michal Tal,…
Jan 8, 2024, 10:12 |
Blog
Sunil Verma: A great way to kick off 2024 by attending JPM2024
Sunil Verma, Global Head of Oncology of Medical AstraZeneca, shared a post on LinkedIn: ''A…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Sep 19, 2023, 09:29 |
Insight
Peter Westcott: ... why many patients with DNA mismatch repair deficient (MMRd) tumors may not respond to immunotherapy.
Quoting Peter Westcott, Assistant Professor at the Cold Spring Harbor Lab, on X/Twitter: "Out today,…
Aug 15, 2023, 19:03 |
Career
Kimia Sorouri: The past 2 years immersed in the Harvard University ecosystem has been one of the most rewarding and unexpected experiences of my career.
On LinkedIn, Kimia Sorouri, Research Fellow at Harvard Medical School, stated: "The past 2 years…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube